1999 Institute of Medicine (IOM) Report

In January 1997, the White House Office of National Drug Control Policy (ONDCP) asked the Institute of Medicine to conduct a review of the scientific evidence to asses the potential health benefits and risks of marijuana and its constituent cannabinoids. That review began in August 1997 and culminates in a 222-page report published in book form through the National Academy of Sciences.

Information for this study was gathered through scientific workshops, site visits to cannabis buyersu2019 clubs and HIV/AIDS clinics, analysis of the relevant scientific literature, and extensive consultation with biomedical and social scientists.

The Institute of Medicine was chartered in 1970 by the National Academy of Sciences to enlist distinguished members of the appropriate professions in the examination of policy matters pertaining to the health of the public. In this, the Institute acts under both the Academyu2019s 1863 congressional charter responsibility to be an advisor to the federal government and its own initiative in identifying issues of medical care, research, and education.

This study was supported under Contract No. DC7C02 from the Executive Office of the President, Office of National Drug Control Policy.


Co-Principal Investigators:
  • John A. Benson, Jr., M.D. and
  • Stanley J. Watson, Jr., M.D.

Study Director:

  • Janet E. Joy, Ph.D.